These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 19160079

  • 1. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D, Johnsen H, Juelsrud A, Løvhaug D.
    Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
    [Abstract] [Full Text] [Related]

  • 2. The involvement of pro-inflammatory cytokines in nephrogenic systemic fibrosis - a mechanistic hypothesis based on preclinical results from a rat model treated with gadodiamide.
    Steger-Hartmann T, Raschke M, Riefke B, Pietsch H, Sieber MA, Walter J.
    Exp Toxicol Pathol; 2009 Nov; 61(6):537-52. PubMed ID: 19131226
    [Abstract] [Full Text] [Related]

  • 3. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ.
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [Abstract] [Full Text] [Related]

  • 4. Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
    Pietsch H, Lengsfeld P, Steger-Hartmann T, Löwe A, Frenzel T, Hütter J, Sieber MA.
    Invest Radiol; 2009 Apr; 44(4):226-33. PubMed ID: 19252439
    [Abstract] [Full Text] [Related]

  • 5. Evaluating the role of zinc in the occurrence of fibrosis of the skin: a preclinical study.
    Pietsch H, Pering C, Lengsfeld P, Walter J, Steger-Hartmann T, Golfier S, Frenzel T, Hütter J, Weinmann HJ, Sieber MA.
    J Magn Reson Imaging; 2009 Aug; 30(2):374-83. PubMed ID: 19629978
    [Abstract] [Full Text] [Related]

  • 6. Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
    Fretellier N, Bouzian N, Parmentier N, Bruneval P, Jestin G, Factor C, Mandet C, Daubiné F, Massicot F, Laprévote O, Hollenbeck C, Port M, Idée JM, Corot C.
    Toxicol Sci; 2013 Jan; 131(1):259-70. PubMed ID: 22977165
    [Abstract] [Full Text] [Related]

  • 7. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P.
    Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of NSF: New evidence challenging the prevailing theory.
    Newton BB, Jimenez SA.
    J Magn Reson Imaging; 2009 Dec; 30(6):1277-83. PubMed ID: 19937925
    [Abstract] [Full Text] [Related]

  • 11. Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand.
    Sieber MA, Lengsfeld P, Walter J, Schirmer H, Frenzel T, Siegmund F, Weinmann HJ, Pietsch H.
    J Magn Reson Imaging; 2008 May; 27(5):955-62. PubMed ID: 18425843
    [Abstract] [Full Text] [Related]

  • 12. In an animal model nephrogenic systemic fibrosis cannot be induced by intraperitoneal injection of high-dose gadolinium based contrast agents.
    Langer RD, Lorke DE, Neidl van Gorkom KF, Petroianu G, Azimullah S, Nurulain SM, Singh S, Fuchsjäger M.
    Eur J Radiol; 2012 Oct; 81(10):2562-7. PubMed ID: 22304979
    [Abstract] [Full Text] [Related]

  • 13. [Nephrogenic systemic fibrosis--new clinical entity].
    Prvulović M.
    Med Pregl; 2008 Oct; 61(9-10):439-41. PubMed ID: 19203058
    [Abstract] [Full Text] [Related]

  • 14. Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron.
    Hope TA, High WA, Leboit PE, Chaopathomkul B, Rogut VS, Herfkens RJ, Brasch RC.
    Radiology; 2009 Nov; 253(2):390-8. PubMed ID: 19789237
    [Abstract] [Full Text] [Related]

  • 15. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd AS, Sanyal S, Abraham JL.
    J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 20. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK, Thomsen HS.
    Nephron Clin Pract; 2008 Oct; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.